GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » E10

Medy-Tox (XKRX:086900) E10 : ₩7,326.51 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Medy-Tox's adjusted earnings per share data for the three months ended in Mar. 2024 was ₩-363.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩7,326.51 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Medy-Tox's average E10 Growth Rate was -2.10% per year. During the past 3 years, the average E10 Growth Rate was 13.50% per year. During the past 5 years, the average E10 Growth Rate was 7.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Medy-Tox was 13.50% per year. The lowest was 7.30% per year. And the median was 8.70% per year.

As of today (2024-06-08), Medy-Tox's current stock price is ₩138900.00. Medy-Tox's E10 for the quarter that ended in Mar. 2024 was ₩7,326.51. Medy-Tox's Shiller PE Ratio of today is 18.96.

During the past 13 years, the highest Shiller PE Ratio of Medy-Tox was 132.94. The lowest was 13.28. And the median was 29.27.


Medy-Tox E10 Historical Data

The historical data trend for Medy-Tox's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medy-Tox E10 Chart

Medy-Tox Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,743.49 5,116.47 6,729.58 7,373.00 7,481.07

Medy-Tox Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,485.58 7,576.72 7,604.32 7,481.07 7,326.51

Competitive Comparison of Medy-Tox's E10

For the Biotechnology subindustry, Medy-Tox's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medy-Tox's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medy-Tox's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medy-Tox's Shiller PE Ratio falls into.



Medy-Tox E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medy-Tox's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-363/118.8477*118.8477
=-363.000

Current CPI (Mar. 2024) = 118.8477.

Medy-Tox Quarterly Data

per share eps CPI Adj_EPS
201406 1,303.610 99.353 1,559.400
201409 3,316.440 99.608 3,957.024
201412 1,008.040 99.098 1,208.937
201503 1,302.800 99.720 1,552.695
201506 1,796.230 100.050 2,133.711
201509 1,600.000 100.110 1,899.474
201512 1,753.890 100.220 2,079.882
201603 2,080.410 100.560 2,458.750
201606 2,437.860 100.790 2,874.631
201609 2,234.300 101.460 2,617.203
201612 2,311.660 101.560 2,705.154
201703 2,608.040 102.850 3,013.705
201706 3,160.100 102.610 3,660.176
201709 2,046.210 103.490 2,349.863
201712 2,982.600 102.990 3,441.840
201803 3,335.980 104.100 3,808.584
201806 2,770.080 104.130 3,161.602
201809 2,222.090 105.650 2,499.671
201812 2,842.950 104.350 3,237.931
201903 2,101.730 104.490 2,390.523
201906 1,622.840 104.880 1,838.966
201909 478.885 105.200 541.011
201912 -33.631 105.120 -38.023
202003 -919.123 105.540 -1,035.017
202006 -918.259 104.870 -1,040.650
202009 -8.638 106.200 -9.667
202012 -2,994.800 105.765 -3,365.232
202103 8,629.480 107.357 9,553.098
202106 4,848.070 107.579 5,355.916
202109 3,226.300 108.759 3,525.571
202112 -1,502.720 109.676 -1,628.380
202203 639.048 111.806 679.297
202206 3,020.000 114.083 3,146.136
202209 2,098.100 114.831 2,171.484
202212 -19.714 115.200 -20.338
202303 699.000 116.550 712.783
202306 1,273.000 117.140 1,291.559
202309 -353.000 119.111 -352.219
202312 -309.000 118.848 -309.000
202403 -363.000 118.848 -363.000

Add all the adjusted EPS together and divide 10 will get our e10.


Medy-Tox  (XKRX:086900) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Medy-Tox's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=138900.00/7326.51
=18.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Medy-Tox was 132.94. The lowest was 13.28. And the median was 29.27.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Medy-Tox E10 Related Terms

Thank you for viewing the detailed overview of Medy-Tox's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Medy-Tox (XKRX:086900) Business Description

Traded in Other Exchanges
N/A
Address
641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885
Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox (XKRX:086900) Headlines

No Headlines